Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 35 (1) , 108944
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (5101BX000196-04, CA16672, CA116021-S1, CA116021, IIDRP-16-001, R37 CA233770-01, P50CA098131)
- Breast Cancer Research Foundation (5101BX000196-04, CA16672, CA116021-S1, CA116021, IIDRP-16-001, R37 CA233770-01, P50CA098131)
- National Institutes of Health (5101BX000196-04, CA16672, CA116021-S1, CA116021, IIDRP-16-001, R37 CA233770-01, P50CA098131)
- National Cancer Institute (5101BX000196-04, CA16672, CA116021-S1, CA116021, IIDRP-16-001, R37 CA233770-01, P50CA098131)
This publication has 68 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Staying aliveCell Cycle, 2012
- mTOR SignalingCold Spring Harbor Perspectives in Biology, 2011
- Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycleMetabolomics, 2011
- CC Chemokine Receptor 5 (CCR5) DesensitizationJournal of Biological Chemistry, 2010
- Cellular Metabolic Stress: Considering How Cells Respond to Nutrient ExcessMolecular Cell, 2010
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Research, 2009
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell RecruitmentCancer Research, 2009
- Mitochondria in cancer cells: what is so special about them?Trends in Cell Biology, 2008
- Linking stress, oxidation and the chemokine systemEuropean Journal of Immunology, 2005